Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02542553
Other study ID # Bilateral BAL in VAP
Secondary ID
Status Completed
Phase N/A
First received August 25, 2015
Last updated September 3, 2015
Start date February 2013
Est. completion date July 2014

Study information

Verified date August 2015
Source Catholic University of the Sacred Heart
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess microbiologic concordance rates between right- and left-lung bronchoalveolar lavage cultures from patients with suspected ventilator-associated pneumonia, identify predictors of concordance, and evaluate the impact of discordant microbiology on clinicians' ability to prescribe appropriate antibiotic treatments, the investigators conducted a prospective observational study in the general intensive care unit of a large university hospital.


Description:

Bronchoscopic sampling of lower respiratory tract secretions is widely used in intensive care units (ICUs) for the microbiological diagnosis of ventilator-associated pneumonia (VAP). However, the importance of selecting a specific lung segment for sampling is still a matter of debate.

Non-bronchoscopic blind mini-bronchoalveolar lavage (BAL) is currently used for the diagnosis of VAP with satisfactory sensitivity and specificity. In the presence of pneumonia, microbiologic concordance between the left and right lungs becomes crucial. If concordance is low, the reliability of blind sampling becomes questionable.

When the bacterial distribution in the right and left lungs of VAP patients has been investigated using bronchoscopic sampling techniques, rates of microbiological concordance between the two specimens have varied widely (from 53% to 92%). The factors potentially associated with concordant culture yields have never been explored, and it is unclear whether the use of guided, bilateral lung sampling would actually improve the appropriateness of the antibiotic regimens prescribed for patients with suspected VAP.

The primary objective of this study is to assess the frequency of microbiologic concordance between the right- and left-lung samples in ICU patients undergoing bronchoscopic BAL performed with two different fiberoptic bronchoscopes for the suspicion of VAP. Secondary objectives are to identify factors associated with such concordance and to evaluate the suitability of treatments prescribed based on unilateral vs. bilateral BAL cultures.


Recruitment information / eligibility

Status Completed
Enrollment 79
Est. completion date July 2014
Est. primary completion date July 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- invasive mechanical ventilation of = 48 hours

- clinically suspected pneumonia (simplified Clinical Pulmonary Infectious Score exceeded 6 or chest radiographs with a new or progressive pulmonary infiltrate in a patient with at least two of the following: purulent respiratory secretions, temperature >38°C or <36°C, white blood cell count >12,000/mm3 or <4,000/mm3)

Exclusion Criteria:

- age <18 years

- pregnancy

- absence of informed consent

- an arterial oxygen partial pressure to inspired oxygen fraction ratio (PaO2:FiO2) of =150

- use of positive end-expiratory pressure (PEEP) >10 cmH2O

- active uncontrolled bronchospasm

- unstable angina or recent (<6 weeks) myocardial infarction

- unstable arrhythmia

- intracranial hypertension

- platelet count =20,000/mm3

- international normalized ratio (INR) or activated partial thromboplastin time (aPTT) ratio >1.5

- documented treatment-limitation orders in the patient's chart

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Procedure:
Bilateral BAL


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Catholic University of the Sacred Heart

References & Publications (7)

Butler KL, Best IM, Oster RA, Katon-Benitez I, Lynn Weaver W, Bumpers HL. Is bilateral protected specimen brush sampling necessary for the accurate diagnosis of ventilator-associated pneumonia? J Trauma. 2004 Aug;57(2):316-22. — View Citation

Esperatti M, Ferrer M, Theessen A, Liapikou A, Valencia M, Saucedo LM, Zavala E, Welte T, Torres A. Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. Am J Respir Crit Care Med. 2010 Dec 15;1 — View Citation

Jackson SR, Ernst NE, Mueller EW, Butler KL. Utility of bilateral bronchoalveolar lavage for the diagnosis of ventilator-associated pneumonia in critically ill surgical patients. Am J Surg. 2008 Feb;195(2):159-63. — View Citation

Marquette CH, Herengt F, Saulnier F, Nevierre R, Mathieu D, Courcol R, Ramon P. Protected specimen brush in the assessment of ventilator-associated pneumonia. Selection of a certain lung segment for bronchoscopic sampling is unnecessary. Chest. 1993 Jan;1 — View Citation

Meduri GU, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest. 1992 Nov;102(5 Suppl 1):557S-564S. Review. — View Citation

Meduri GU, Reddy RC, Stanley T, El-Zeky F. Pneumonia in acute respiratory distress syndrome. A prospective evaluation of bilateral bronchoscopic sampling. Am J Respir Crit Care Med. 1998 Sep;158(3):870-5. — View Citation

Zaccard CR, Schell RF, Spiegel CA. Efficacy of bilateral bronchoalveolar lavage for diagnosis of ventilator-associated pneumonia. J Clin Microbiol. 2009 Sep;47(9):2918-24. doi: 10.1128/JCM.00747-09. Epub 2009 Jul 15. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Comparison of antibiotic regimens chosen on the basis of right or left-lung culture results alone with regimens chosen on the basis of bilateral culture results, by performing a simulated prescribing experiment. For each enrolled patient, actual treatment decisions are made by the ICU attending physicians in charge of the case on the basis of the results of bilateral BAL culture and sensitivity analyses. Later, at the end of the study, data for patients with discordant BAL cultures are reviewed in a simulated prescribing session by a second team composed of an ICU physician and an infectious disease specialist. The team is asked to propose an appropriate antimicrobial regimen based on the culture and in vitro antimicrobial susceptibility data for the right-lung BAL sample alone, the left-lung BAL sample alone, and the right and left BAL samples. Each microbiological report is presented separately to the team with a summary of the patient's relevant clinical data. The prescribed regimen is defined as appropriate if it provides active coverage for all of the organisms identified in both BAL specimens. At 18 months after study initiation No
Primary Rate of microbiologic concordance between the right- and left-lung samples Pneumonia is microbiologically confirmed when the quantitative culture of one or both BAL specimens is positive at significant growth for at least one potential bacterial pathogen. Right and left BAL cultures are classified as concordant when both are positive for the same organism(s) or when neither show any growth. Cultures are classified as discordant when at least one of the microorganisms isolated from one specimen is not recovered from the contralateral specimen. After at least 48 hours of invasive mechanical ventilation No
Secondary Possible association between purulent secretions and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between duration of mechanical ventilation and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between duration of ICU stay and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between duration of hospital stay and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between immunosuppression and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between antibiotic treatment and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between radiological infiltrate and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between body temperature and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between WBC count and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between PaO2:FiO2 and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between PEEP and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between CPIS and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between type of humidification and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between procalcitonin and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
Secondary Possible association between C-reactive protein and microbiologic concordance between right- and left-lung BAL cultures At an expected average of 48 hours after bronchoscopy No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06370598 - Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia Phase 1/Phase 2
Terminated NCT02806141 - Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates Phase 3
Completed NCT01765530 - Efficacy Study of a Novel Device to Clean the Endotracheal Tube N/A
Completed NCT00521677 - Comparison Between Two Methods of Oral Care on the Incidence of VAP N/A
Completed NCT00529776 - Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation Therapy N/A
Completed NCT03401463 - Assesment of the Endotracheal Tube Cuff Pressure Values in ICU Pateints Before and After Training Seminar N/A
Completed NCT02950519 - Endotracheal Tube Cuff Pressures in Ventilated Patients N/A
Completed NCT01875692 - Can we Better Understand the Development of VAP and Eventually Predict and Prevent it? N/A
Completed NCT00515034 - A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia Phase 2
Recruiting NCT05117125 - Biomarkers for Ventilator-associated Pneumonia
Completed NCT04755972 - Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2 N/A
Terminated NCT02940626 - Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus. Phase 2
Completed NCT01577862 - Colistin and Rifampicin for MDR-Acinetobacter Phase 3
Completed NCT00572559 - Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus Phase 4
Withdrawn NCT04566172 - Preoperative Optimization to Improve Functional Status N/A
Recruiting NCT04215692 - Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients N/A
Completed NCT03816956 - Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 Phase 3
Active, not recruiting NCT01123681 - Intubation and Extubation Over 48 Hours Mechanical Ventilation N/A
Recruiting NCT04839653 - Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria N/A
Recruiting NCT03527992 - Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia N/A